# FDA Inspection 1174664 - LFB USA, Inc. - April 08, 2022

Source: https://www.keypedia.com/records/fda_inspections/lfb-usa-inc/32131f58-e830-4004-90ba-bbf5cea1313d
Source feed: FDA_Inspections

> FDA Inspection 1174664 for LFB USA, Inc. on April 08, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1174664
- Company Name: LFB USA, Inc.
- Inspection Date: 2022-04-08
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1244007 - 2024-06-28](https://www.keypedia.com/records/fda_inspections/lfb-usa-inc/0201dc4b-8217-4f94-b83c-9a9bb1c59d55)
- [FDA Inspection 1039570 - 2017-08-22](https://www.keypedia.com/records/fda_inspections/lfb-usa-inc/1b4d1b83-8f51-46ae-95b8-cd8437ce7b57)

Company: https://www.keypedia.com/companies/lfb-usa-inc/0ce33194-ad37-4a33-ac26-fb8a40ba3c7c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d